Loading…
0118 Increased Circulating Levels and Peripheral Tissue Promoter DNA Methylation of the Hormone FGF-21 Following Acute Sleep Loss in Humans
Introduction Sleep loss and circadian misalignment alter energy metabolism in a tissue-specific manner. FGF-21 has tissue-specific and nutrient-dependent effects on metabolic substrate utilization, e.g. increasing insulin sensitivity of adipose tissue, yet its role has not been investigated in human...
Saved in:
Published in: | Sleep (New York, N.Y.) N.Y.), 2019-04, Vol.42 (Supplement_1), p.A48-A49 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c1587-44a86d4462d5dae202dd6b4575130f964a4c2d36e53c36d45b4af22640e897303 |
---|---|
cites | |
container_end_page | A49 |
container_issue | Supplement_1 |
container_start_page | A48 |
container_title | Sleep (New York, N.Y.) |
container_volume | 42 |
creator | Espes, Daniel Carlson, Per-Ola Benedict, Christian Cedernaes, Jonathan |
description | Introduction Sleep loss and circadian misalignment alter energy metabolism in a tissue-specific manner. FGF-21 has tissue-specific and nutrient-dependent effects on metabolic substrate utilization, e.g. increasing insulin sensitivity of adipose tissue, yet its role has not been investigated in humans exposed to acute sleep loss. Increased levels of FGF-21 are also seen in metabolic disease such as type 2 diabetes and obesity. Methods In a randomized, 2-session, 2-condition, crossover clinical study involving 15 healthy young men, serum samples were obtained in the fasted state and after an oral glucose tolerance test (OGTT), following one night of sleep loss and following one night of sleep (8.5 hrs), for analysis of serum FGF-21 levels by ELISA. Skeletal muscle and adipose tissue biopsies were collected in the morning fasting state in both conditions for DNA methylation and qPCR analyses. Results Even though the OGTT increased FGF-21 levels across conditions (P=0.0001), FGF-21 levels were significantly higher across timepoints after acute sleep loss compared with after sleep (p=0.022). A similar significant increase was seen in a separate cohort with cumulatively matching partial sleep loss (8.5 hrs). A sub-group analysis revealed that only participants with low but not high (P=0.031 vs P=0.41) insulin sensitivity, in response to the OGTT after sleep loss, exhibited a significant increase in serum FGF-21 levels after sleep loss compared with normal sleep. The promoter region of the FGF-21 gene exhibited increased DNA methylation after sleep loss compared with sleep (P |
doi_str_mv | 10.1093/sleep/zsz067.117 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2365156150</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2365156150</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1587-44a86d4462d5dae202dd6b4575130f964a4c2d36e53c36d45b4af22640e897303</originalsourceid><addsrcrecordid>eNotkM1Pg0AQxTdGE2v17nESz7S77AdwbKr9SFCbWM9kC4OlARZ3QdP-C_7TgvU0mcx7b15-hNwzOmE04lNXIjbTkztRFUwYCy7IiElJvai_XpIRZYp5IaPymtw4d6D9LiI-Ij-UsRDWdWpRO8xgXti0K3Vb1B8Q4xeWDnSdwQZt0ezR6hK2hXMdwsaayrRo4fFlBs_Y7o-Dy9Rgcmj3CCtjK1MjLJYLz2ewMGVpvofUWdq1CG9DXYiNc1DUsOoqXbtbcpXr0uHd_xyT98XTdr7y4tflej6LvZTJMPCE0KHKhFB-JjONPvWzTO2EDCTjNI-U0CL1M65Q8pT3QrkTOvd9JSiGUcApH5OHc25jzWeHrk0OprN1_zLxuZJMKiYHFT2rUtu3tJgnjS0qbY8Jo8mAPPlDnpyRJz1y_gt5E3V7</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2365156150</pqid></control><display><type>article</type><title>0118 Increased Circulating Levels and Peripheral Tissue Promoter DNA Methylation of the Hormone FGF-21 Following Acute Sleep Loss in Humans</title><source>Oxford Journals Online</source><source>Alma/SFX Local Collection</source><creator>Espes, Daniel ; Carlson, Per-Ola ; Benedict, Christian ; Cedernaes, Jonathan</creator><creatorcontrib>Espes, Daniel ; Carlson, Per-Ola ; Benedict, Christian ; Cedernaes, Jonathan</creatorcontrib><description>Introduction Sleep loss and circadian misalignment alter energy metabolism in a tissue-specific manner. FGF-21 has tissue-specific and nutrient-dependent effects on metabolic substrate utilization, e.g. increasing insulin sensitivity of adipose tissue, yet its role has not been investigated in humans exposed to acute sleep loss. Increased levels of FGF-21 are also seen in metabolic disease such as type 2 diabetes and obesity. Methods In a randomized, 2-session, 2-condition, crossover clinical study involving 15 healthy young men, serum samples were obtained in the fasted state and after an oral glucose tolerance test (OGTT), following one night of sleep loss and following one night of sleep (8.5 hrs), for analysis of serum FGF-21 levels by ELISA. Skeletal muscle and adipose tissue biopsies were collected in the morning fasting state in both conditions for DNA methylation and qPCR analyses. Results Even though the OGTT increased FGF-21 levels across conditions (P=0.0001), FGF-21 levels were significantly higher across timepoints after acute sleep loss compared with after sleep (p=0.022). A similar significant increase was seen in a separate cohort with cumulatively matching partial sleep loss (8.5 hrs). A sub-group analysis revealed that only participants with low but not high (P=0.031 vs P=0.41) insulin sensitivity, in response to the OGTT after sleep loss, exhibited a significant increase in serum FGF-21 levels after sleep loss compared with normal sleep. The promoter region of the FGF-21 gene exhibited increased DNA methylation after sleep loss compared with sleep (P<0.05), both in skeletal muscle and adipose tissue. Conclusion Increased circulating levels of FGF-21 may constitute a counter-regulatory mechanism by which the body tries to counteract adverse effects of disrupted sleep and circadian rhythms. Increased FGF-21 could have effects on peripheral metabolism that are in line with those previously observed after overnight wakefulness. It remains to be determined whether the altered DNA methylation of the promoter of FGF-21 in peripheral tissues after sleep loss results in long-term shifts in peripheral release of FGF-21 across the sleep/wake cycle. Support (If Any) The Swedish Society for Medical Research, the Swedish Research Council and the following foundation: Swedish Brain, Åke Wiberg, NovoNordisk, Bissen Brainwalk.</description><identifier>ISSN: 0161-8105</identifier><identifier>EISSN: 1550-9109</identifier><identifier>DOI: 10.1093/sleep/zsz067.117</identifier><language>eng</language><publisher>Westchester: Oxford University Press</publisher><subject>Deoxyribonucleic acid ; DNA ; DNA methylation ; Metabolism ; Musculoskeletal system ; Sleep deprivation</subject><ispartof>Sleep (New York, N.Y.), 2019-04, Vol.42 (Supplement_1), p.A48-A49</ispartof><rights>Sleep Research Society 2019. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1587-44a86d4462d5dae202dd6b4575130f964a4c2d36e53c36d45b4af22640e897303</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Espes, Daniel</creatorcontrib><creatorcontrib>Carlson, Per-Ola</creatorcontrib><creatorcontrib>Benedict, Christian</creatorcontrib><creatorcontrib>Cedernaes, Jonathan</creatorcontrib><title>0118 Increased Circulating Levels and Peripheral Tissue Promoter DNA Methylation of the Hormone FGF-21 Following Acute Sleep Loss in Humans</title><title>Sleep (New York, N.Y.)</title><description>Introduction Sleep loss and circadian misalignment alter energy metabolism in a tissue-specific manner. FGF-21 has tissue-specific and nutrient-dependent effects on metabolic substrate utilization, e.g. increasing insulin sensitivity of adipose tissue, yet its role has not been investigated in humans exposed to acute sleep loss. Increased levels of FGF-21 are also seen in metabolic disease such as type 2 diabetes and obesity. Methods In a randomized, 2-session, 2-condition, crossover clinical study involving 15 healthy young men, serum samples were obtained in the fasted state and after an oral glucose tolerance test (OGTT), following one night of sleep loss and following one night of sleep (8.5 hrs), for analysis of serum FGF-21 levels by ELISA. Skeletal muscle and adipose tissue biopsies were collected in the morning fasting state in both conditions for DNA methylation and qPCR analyses. Results Even though the OGTT increased FGF-21 levels across conditions (P=0.0001), FGF-21 levels were significantly higher across timepoints after acute sleep loss compared with after sleep (p=0.022). A similar significant increase was seen in a separate cohort with cumulatively matching partial sleep loss (8.5 hrs). A sub-group analysis revealed that only participants with low but not high (P=0.031 vs P=0.41) insulin sensitivity, in response to the OGTT after sleep loss, exhibited a significant increase in serum FGF-21 levels after sleep loss compared with normal sleep. The promoter region of the FGF-21 gene exhibited increased DNA methylation after sleep loss compared with sleep (P<0.05), both in skeletal muscle and adipose tissue. Conclusion Increased circulating levels of FGF-21 may constitute a counter-regulatory mechanism by which the body tries to counteract adverse effects of disrupted sleep and circadian rhythms. Increased FGF-21 could have effects on peripheral metabolism that are in line with those previously observed after overnight wakefulness. It remains to be determined whether the altered DNA methylation of the promoter of FGF-21 in peripheral tissues after sleep loss results in long-term shifts in peripheral release of FGF-21 across the sleep/wake cycle. Support (If Any) The Swedish Society for Medical Research, the Swedish Research Council and the following foundation: Swedish Brain, Åke Wiberg, NovoNordisk, Bissen Brainwalk.</description><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>DNA methylation</subject><subject>Metabolism</subject><subject>Musculoskeletal system</subject><subject>Sleep deprivation</subject><issn>0161-8105</issn><issn>1550-9109</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNotkM1Pg0AQxTdGE2v17nESz7S77AdwbKr9SFCbWM9kC4OlARZ3QdP-C_7TgvU0mcx7b15-hNwzOmE04lNXIjbTkztRFUwYCy7IiElJvai_XpIRZYp5IaPymtw4d6D9LiI-Ij-UsRDWdWpRO8xgXti0K3Vb1B8Q4xeWDnSdwQZt0ezR6hK2hXMdwsaayrRo4fFlBs_Y7o-Dy9Rgcmj3CCtjK1MjLJYLz2ewMGVpvofUWdq1CG9DXYiNc1DUsOoqXbtbcpXr0uHd_xyT98XTdr7y4tflej6LvZTJMPCE0KHKhFB-JjONPvWzTO2EDCTjNI-U0CL1M65Q8pT3QrkTOvd9JSiGUcApH5OHc25jzWeHrk0OprN1_zLxuZJMKiYHFT2rUtu3tJgnjS0qbY8Jo8mAPPlDnpyRJz1y_gt5E3V7</recordid><startdate>20190413</startdate><enddate>20190413</enddate><creator>Espes, Daniel</creator><creator>Carlson, Per-Ola</creator><creator>Benedict, Christian</creator><creator>Cedernaes, Jonathan</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>20190413</creationdate><title>0118 Increased Circulating Levels and Peripheral Tissue Promoter DNA Methylation of the Hormone FGF-21 Following Acute Sleep Loss in Humans</title><author>Espes, Daniel ; Carlson, Per-Ola ; Benedict, Christian ; Cedernaes, Jonathan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1587-44a86d4462d5dae202dd6b4575130f964a4c2d36e53c36d45b4af22640e897303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>DNA methylation</topic><topic>Metabolism</topic><topic>Musculoskeletal system</topic><topic>Sleep deprivation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Espes, Daniel</creatorcontrib><creatorcontrib>Carlson, Per-Ola</creatorcontrib><creatorcontrib>Benedict, Christian</creatorcontrib><creatorcontrib>Cedernaes, Jonathan</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Health & Medical Complete</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Psychology Database (ProQuest)</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>Sleep (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Espes, Daniel</au><au>Carlson, Per-Ola</au><au>Benedict, Christian</au><au>Cedernaes, Jonathan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>0118 Increased Circulating Levels and Peripheral Tissue Promoter DNA Methylation of the Hormone FGF-21 Following Acute Sleep Loss in Humans</atitle><jtitle>Sleep (New York, N.Y.)</jtitle><date>2019-04-13</date><risdate>2019</risdate><volume>42</volume><issue>Supplement_1</issue><spage>A48</spage><epage>A49</epage><pages>A48-A49</pages><issn>0161-8105</issn><eissn>1550-9109</eissn><abstract>Introduction Sleep loss and circadian misalignment alter energy metabolism in a tissue-specific manner. FGF-21 has tissue-specific and nutrient-dependent effects on metabolic substrate utilization, e.g. increasing insulin sensitivity of adipose tissue, yet its role has not been investigated in humans exposed to acute sleep loss. Increased levels of FGF-21 are also seen in metabolic disease such as type 2 diabetes and obesity. Methods In a randomized, 2-session, 2-condition, crossover clinical study involving 15 healthy young men, serum samples were obtained in the fasted state and after an oral glucose tolerance test (OGTT), following one night of sleep loss and following one night of sleep (8.5 hrs), for analysis of serum FGF-21 levels by ELISA. Skeletal muscle and adipose tissue biopsies were collected in the morning fasting state in both conditions for DNA methylation and qPCR analyses. Results Even though the OGTT increased FGF-21 levels across conditions (P=0.0001), FGF-21 levels were significantly higher across timepoints after acute sleep loss compared with after sleep (p=0.022). A similar significant increase was seen in a separate cohort with cumulatively matching partial sleep loss (8.5 hrs). A sub-group analysis revealed that only participants with low but not high (P=0.031 vs P=0.41) insulin sensitivity, in response to the OGTT after sleep loss, exhibited a significant increase in serum FGF-21 levels after sleep loss compared with normal sleep. The promoter region of the FGF-21 gene exhibited increased DNA methylation after sleep loss compared with sleep (P<0.05), both in skeletal muscle and adipose tissue. Conclusion Increased circulating levels of FGF-21 may constitute a counter-regulatory mechanism by which the body tries to counteract adverse effects of disrupted sleep and circadian rhythms. Increased FGF-21 could have effects on peripheral metabolism that are in line with those previously observed after overnight wakefulness. It remains to be determined whether the altered DNA methylation of the promoter of FGF-21 in peripheral tissues after sleep loss results in long-term shifts in peripheral release of FGF-21 across the sleep/wake cycle. Support (If Any) The Swedish Society for Medical Research, the Swedish Research Council and the following foundation: Swedish Brain, Åke Wiberg, NovoNordisk, Bissen Brainwalk.</abstract><cop>Westchester</cop><pub>Oxford University Press</pub><doi>10.1093/sleep/zsz067.117</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0161-8105 |
ispartof | Sleep (New York, N.Y.), 2019-04, Vol.42 (Supplement_1), p.A48-A49 |
issn | 0161-8105 1550-9109 |
language | eng |
recordid | cdi_proquest_journals_2365156150 |
source | Oxford Journals Online; Alma/SFX Local Collection |
subjects | Deoxyribonucleic acid DNA DNA methylation Metabolism Musculoskeletal system Sleep deprivation |
title | 0118 Increased Circulating Levels and Peripheral Tissue Promoter DNA Methylation of the Hormone FGF-21 Following Acute Sleep Loss in Humans |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T03%3A59%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=0118%20Increased%20Circulating%20Levels%20and%20Peripheral%20Tissue%20Promoter%20DNA%20Methylation%20of%20the%20Hormone%20FGF-21%20Following%20Acute%20Sleep%20Loss%20in%20Humans&rft.jtitle=Sleep%20(New%20York,%20N.Y.)&rft.au=Espes,%20Daniel&rft.date=2019-04-13&rft.volume=42&rft.issue=Supplement_1&rft.spage=A48&rft.epage=A49&rft.pages=A48-A49&rft.issn=0161-8105&rft.eissn=1550-9109&rft_id=info:doi/10.1093/sleep/zsz067.117&rft_dat=%3Cproquest_cross%3E2365156150%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1587-44a86d4462d5dae202dd6b4575130f964a4c2d36e53c36d45b4af22640e897303%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2365156150&rft_id=info:pmid/&rfr_iscdi=true |